Fulminant leptomeningeal disease diagnosed as comutant H3F3A and FGFR diffuse midline glioma

Diffuse midline gliomas present a particularly intricate and challenging clinical scenario. This rare case involves a patient with comutant H3F3A and FGFR diffuse midline glioma with a clinical presentation of fulminant leptomeningitis. A 22‐year‐old male presented with fatal and fulminant diffuse l...

Full description

Saved in:
Bibliographic Details
Published in:Annals of clinical and translational neurology Vol. 11; no. 11; pp. 3037 - 3041
Main Authors: Benistant, Larysa, Reita, Damien, Schenck, Maleka, Castelain, Vincent, Cebula, Hélène, Lhermitte, Benoît, Bender, Laura
Format: Journal Article
Language:English
Published: United States John Wiley & Sons, Inc 01.11.2024
John Wiley and Sons Inc
Wiley
Subjects:
ISSN:2328-9503, 2328-9503
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Diffuse midline gliomas present a particularly intricate and challenging clinical scenario. This rare case involves a patient with comutant H3F3A and FGFR diffuse midline glioma with a clinical presentation of fulminant leptomeningitis. A 22‐year‐old male presented with fatal and fulminant diffuse leptomeningitis. Next‐generation sequencing of plasma and cerebrospinal circulating tumour DNA revealed diffuse midline gliomas with H3F3A and FGFR mutations. Methylome analysis of meningeal tissue collected during autopsy confirmed the diagnosis. Liquid biopsy plays a crucial role in the diagnosis of diffuse midline gliomas, mainly those with exclusively leptomeningeal presentations.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Case Study-2
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:2328-9503
2328-9503
DOI:10.1002/acn3.52180